These newer medications , including Semaglutide , belong to a category of drugs called GLP-1 agents. Primarily approved for treating high blood sugar, they operate by encouraging the organism to secrete https://www.how-dept.com/mayiknow/detail/?p=5-Research-backed-Ways-to-Reduce-GLP-1-Side-Effects-AVJ2xN0YiTBcJ